🇺🇸 FDA
Patent

US 9272044

Injectable flowable composition buprenorphine

granted A61KA61K31/00A61K31/4748

Quick answer

US patent 9272044 (Injectable flowable composition buprenorphine) held by Indivior UK Limited expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Indivior UK Limited
Grant date
Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K31/00, A61K31/4748, A61K31/485, A61K47/22